Molecular therapy refers to strategies for delivering a needed gene product to a patient with the goal of improving their health. Genes can be delivered to cells in the body using genetically engineered viruses, and the cells that receive the gene make the protein that the gene encodes. Ex vivo gene therapy, on the other hand, is a cell-based kind of gene therapy in which the patient gets cells that have been modified to create the required gene product. Researchers and healthcare workers can learn about the latest molecular diagnostic and therapeutic techniques, as well as how they are used in precision medicine, in Molecular Diagnosis & Therapy. Molecular imaging and therapy are a new field of study that combines cell biology, molecular biology, and diagnostic imaging to detect and treat disease at the cellular level. Physicians can now see the anatomical structure of a disease with current imaging technology.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico